The reduction of TAK1 expression in aging human brains was shown to cooperate with heterozygous loss-of-TBK1 to promote late onset ALS/FTD-like pathology mediated by decreased RIPK1 inhibition. The gene discussed is RIPK1; the disease is amyotrophic lateral sclerosis.